immune system
• 12 days after infection with LCMV, mice have splenomegaly
|
• after receiving 2 x 104 PFU MCMV, a 4-fold increase in neutrophil number is observed on day 7 compared to wild-type; this resolves by day 14
• 12 days after infection with LCMV, mice show neutrophilia, rather than neutropenia
|
• CD8+ T cells are ~doubled in number in the spleen, after LCMV infection
|
• after receiving 2 x 104 PFU MCMV, a 3-fold increase in monocyte number is observed on day 7 compared to wild-type; this does not resolve
|
• NK cell-mediated cytotoxicity against beta2microglobulin-null cells in vivo and against YAC-1 cells in vitro is abolished
|
• polyclonal stimulation of CTLs show defect in ability to degranulate
|
• the susceptibility of activated mutant macrophages to ex vivo vesicular stomatitis virus (VSV) infection was reversed by the addition of type I interferon
|
• RBCs are seen to reside within vesicles in bone marrow macrophages
|
• germinal center depletion and replacement by macrophages is observed in peripheral lymph nodes after LCMV infection
|
• homozygotes show exaggerated production of Il12, IFNgamma, and type I INF (alpha/beta) 36 hours after inoculation with the virus
• 12 days after infection with LCMV, serum IFNgamma levels show sustained elevation; increased production of IFNgamma by splenic CD8+ T cells is evident
|
• mice are susceptible to infection by mouse cytomegalovirus (MCMV)
(J:105543)
• mice are severely ill and have high viral loads in the spleen five days following infection with MCMV
(J:105543)
• activated macrophages from these mice are susceptible to ex vivo VSV infection
(J:105543)
• when infected with 105 PFU of Smith strain MCMV (mouse cytomegalovirus), mice show severe illness with 4-5 orders of magnitude higher viral titers after 5 days, whereas wild-type C57BL/6 mice survive infection with no signs of illness and very few PFU in the spleen after 5 days
(J:119974)
• dose of 2.5 x 105 PFU MCMV is lethal to mutants and BALB/c controls within 6 days while C57BL/6 controls mice do not exhibit any lethality
(J:119974)
|
• activated macrophages from these mice are susceptible to ex vivo VSV infection
(J:105543)
• hemophagocytic lymphohistiocytosis (HLH) is observed in mice infected with LCMV (lymphocytic choriomeningitis virus - Armstrong strain)
(J:119974)
• infection by LCMV can not be controlled, such that titers are >1000 fold higher in mutants vs controls 12 days after inoculation, except in the liver
(J:119974)
|
hematopoietic system
• 12 days after infection with LCMV, mice have splenomegaly
|
• after receiving 2 x 104 PFU MCMV, a 4-fold increase in neutrophil number is observed on day 7 compared to wild-type; this resolves by day 14
• 12 days after infection with LCMV, mice show neutrophilia, rather than neutropenia
|
• 12 days after infection with LCMV, mice display thrombocytopenia
|
• CD8+ T cells are ~doubled in number in the spleen, after LCMV infection
|
• after receiving 2 x 104 PFU MCMV, a 3-fold increase in monocyte number is observed on day 7 compared to wild-type; this does not resolve
|
• NK cell-mediated cytotoxicity against beta2microglobulin-null cells in vivo and against YAC-1 cells in vitro is abolished
|
• polyclonal stimulation of CTLs show defect in ability to degranulate
|
• the susceptibility of activated mutant macrophages to ex vivo vesicular stomatitis virus (VSV) infection was reversed by the addition of type I interferon
|
• RBCs are seen to reside within vesicles in bone marrow macrophages
|
skeleton
• bone marrow show macrophage infiltration after LCMV infection; hemophagocytosis can be seen
|
growth/size/body
• 12 days after infection with LCMV, mice have splenomegaly
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
familial hemophagocytic lymphohistiocytosis 3 | DOID:0110923 |
OMIM:608898 |
J:119974 |